Abstract Background: In Canada, public drug plans may restrict the use of newer topical
antiglaucoma agents. The goals of this retrospective study were to estimate the proportion of …

The safety of topical à ╒blockers in glaucoma treatment Page 1 Clinical Practice The safety of
topical B-blockers in glaucoma treatment Ivan Goldberg While adverse effects are uncommon …

We conducted a case-control study to measure the risk of pulmonary side effects following
the use of topical glaucoma medications, particularly the [beta] blockers, and to identify …

This set of Viewpoints articles examines the merits of beta-blockers versus other
medications as the primary drug treatment for glaucoma. Ophthalmologists must balance …

Purpose: Prescribing topical beta‐blockers for patients with glaucoma, who are also being
treated with systemic beta‐blockers, raises efficacy and safety concerns. This potentially …

Glaucoma and ocular hypertension are highly prevalent conditions in individuals over the
age of 40 and are commonly seen together in patients with cardiovascular disease. Many of …

Objectives: Topical β-blockers are contraindicated in obstructive pulmonary diseases
(OPDs). In this study we aimed to evaluate through central or local electronic medical …

Purpose: To investigate the use of topical ocular anti-glaucoma medications by
glaucomatous patients with obstructive pulmonary disease and their effect on related …

OBJECTIVE: To review published clinical information on the systemic adverse effects of
ophthalmic β-blockers for the purpose of developing a pilot contraindication/warning system …

The safety profile of the different glaucoma medications is an important issue when initiating
therapy in glaucomatous patients. The decision on which medication to prescribe depends …